Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tivic Health Systems reported that it is changing its corporate name to Valion Bio, Inc. and will begin trading under the new Nasdaq ticker symbol VBIO effective at market open on April 28, 2026.
read more
Tuesday, January 06, 2026
Title21 Health Solutions, a provider of enterprise quality management systems and cell and gene therapy orchestration platforms, announced the acquisition of MyCellHub and its advanced manufacturing execution system (MES) platform, expanding its ...
read more
TILT Biotherapeutics has entered into an agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate its armed oncolytic virus, TILT-123, with avelumab in patients with solid tumors refractory to routine modalities.
read more
Tilray announced its wholly-owned subsidiary Tilray Portugal Unipessoal has received a standard manufacturing license and a GMP certification.
read more
Tigermed, a provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, announce the completion of its acquisition of CRO company Micron, Inc.
read more
Wednesday, August 22, 2018
Kneat has announced another of its tier one pharmaceutical customers is expanding their use of their software platform.
read more
Three top executives from Theorem Clinical Research
will be on the agenda at the 23rd Annual Partnerships in Clinical Trials in Las Vegas, March 31-
April 2.
read more
Tuesday, December 20, 2016
Novasep, a supplier of services and technologies for the life sciences industry, has announced that three of its custom manufacturing sites individually passed the general inspection process of the US Food and Drug Administration (FDA) free of any ...
read more
Three new chemists have joined Contract Research and Development Organization Arcinova’s Active Pharmaceutical Ingredient team.
read more
With more than 2,000 drugs reintroduced for alternative purposes to date, drug repositioning has become a viable solution for pharmaceutical companies to generate additional revenue. The Intellectual Property & Science business of Thomson Reuters, ...
read more
Wednesday, December 05, 2012
The IP & Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals, today announced a preview of its newest intelligence solution, Thomson Reuters Cortellis™ for Clinical Trials ...
read more
Tuesday, September 29, 2020
Thomas H. Lee Partners and Frazier Healthcare have acquired Adare, which will be rebranded Adare Pharma Solutions, a specialty CDMO and provider of advanced pharmaceutical technologies, from TPG Capital.
read more
Thursday, August 14, 2025
THL Partners, a private equity firm investing in middle market growth companies, announced the entry into a definitive agreement to acquire Headlands Research, a multinational network of clinical trial sites, from funds managed by global investment ...
read more
Friday, December 08, 2017
Hologic has received 510(k) clearance from the FDA for its Panther Fusion AdV/hMPV/RV assay, a multiplexed assay that runs on the new Panther Fusion system.
read more
EMD Millipore, the Life Science division of Merck KGaA of Germany, announced today that it will host the third annual EMD Millipore Pharma Forum on June 12, 2012, at the company’s headquarters in Darmstadt, Germany. The event will bring together ...
read more